Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 310

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

Open access
Hoffmann-Vold, Anna-Maria, Maher, Toby M, Philpot, Edward E, Ashrafzadeh, Ali, Barake, Rafic, Barsotti, Simone, Bruni, Cosimo, Carducci, Paolo, Carreira, Patricia E, Castellví, Ivan, Del Galdo, Francesco, Distler, Jörg H W, Foeldvari, Ivan, Fraticelli, Paolo, George, Peter M, Griffiths, Bridget, Guillén-Del-Castillo, Alfredo, Hamid, Abdul Monem, Horváth, Rudolf, Hughes, Michael, Kreuter, Michael, Moazedi-Fuerst, Florentine, Olas, Jacek, Paul, Suman, Rotondo, Cinzia, Rubio-Rivas, Manuel, Seferian, Andrei, Tomčík, Michal, Uzunhan, Yurdagül, Walker, Ulrich A, Więsik-Szewczyk, Ewa, Distler, Oliver·2020·The Lancet Rheumatology

Abstract

BACKGROUND Systemic sclerosis-associated interstitial lung disease (ILD) carries a high mortality risk; expert guidance is required to aid early recognition and treatment. We aimed to develop the first expert consensus and define an algorithm for the identification and management of the condition through application of well established methods. METHODS Evidence-based consensus statements for systemic sclerosis-associated ILD management were established for six domains (ie, risk factors, screening, diagnosis and severity assessment, treatment initiation and options, disease progression, and treatment escalation) using a modified Delphi process based on a systematic literature analysis. A panel of 27 Europe-based pulmonologists, rheumatologists, and internists with expertise in systemic sclerosis-associated ILD participated in three rounds of online surveys, a face-to-face discussion, and a WebEx meeting, followed by two supplemental Delphi rounds, to establish consensus and define a management algorithm. Consensus was considered achieved if at least 80% of panellists indicated agreement or disagreement. FINDINGS Between July 1, 2018, and Aug 27, 2019, consensus agreement was reached for 52 primary statements and six supplemental statements across six domains of management, and an algorithm was defined for clinical practice use. The agreed statements most important for clinical use included: all patients with systemic sclerosis should be screened for systemic sclerosis-associated ILD using high-resolution CT; high-resolution CT is the primary tool for diagnosing ILD in systemic sclerosis; pulmonary function tests support screening and diagnosis; systemic sclerosis-associated ILD severity should be measured with more than one indicator; it is appropriate to treat all severe cases; no pharmacological treatment is an option for some patients; follow-up assessments enable identification of disease progression; progression pace, alongside disease severity, drives decisions to escalate treatment. INTERPRETATION Through a robust modified Delphi process developed by a diverse panel of experts, the first evidence-based consensus statements were established on guidance for the identification and medical management of systemic sclerosis-associated ILD. FUNDING An unrestricted grant from Boehringer Ingelheim International.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2665-9913(19)30144-4

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 310

Metadata

Authors
Hoffmann-Vold, A.-M., Maher, T. M., Philpot, E. E., Ashrafzadeh, A., Barake, R., Barsotti, S., Bruni, C., Carducci, P., Carreira, P. E., Castellví, I., Del Galdo, F., Distler, J. H. W., Foeldvari, I., Fraticelli, P., George, P. M., Griffiths, B., Guillén-Del-Castillo, A., Hamid, A. M., Horváth, R., Hughes, M., Kreuter, M., Moazedi-Fuerst, F., Olas, J., Paul, S., Rotondo, C., Rubio-Rivas, M., Seferian, A., Tomčík, M., Uzunhan, Y., Walker, U. A., Więsik-Szewczyk, E., & Distler, O.
Venue
The Lancet Rheumatology
Publisher
Elsevier BV
Published
2020-02
Volume
2
Issue
2
Pages
e71-e83
ISSN
2665-9913 (ISSN-L)
OpenAlex
W2999054805
Cited by
310
References
54
FWCI
27.15
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. https://app.cochat.ai/papers/10.1016/s2665-9913(19)30144-4
The paper
Hoffmann-Vold, A.-M., Maher, T. M., Philpot, E. E., Ashrafzadeh, A., Barake, R., Barsotti, S., Bruni, C., Carducci, P., Carreira, P. E., Castellví, I., Del Galdo, F., Distler, J. H. W., Foeldvari, I., Fraticelli, P., George, P. M., Griffiths, B., Guillén-Del-Castillo, A., Hamid, A. M., Horváth, R., . . . Distler, O. (2020). The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. The Lancet Rheumatology. https://doi.org/10.1016/s2665-9913(19)30144-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.